利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

474 条记录 (耗时 0.03 秒)

    Medicinal herbal extract carpediol for treating depression
    62.
    发明申请
    Medicinal herbal extract carpediol for treating depression 有权
    药用草药提取物carpediol用于治疗抑郁症

    公开(公告)号：US20030194449A1

    公开(公告)日：2003-10-16

    申请号：US10124132

    申请日：2002-04-16

    申请人： SWEDISH HERBAL INSTITUTE

    发明人： Georg Wikman ,  Alexander Panossian

    IPC分类号： A61K031/7012 ,  A61K031/522 ,  A61K035/78

    CPC分类号： A61K36/41 ,  A61K31/522 ,  A61K31/7012 ,  A61K2300/00

    摘要： The present invention is directed to anti-depressive activity of Crassulaceae special extracts, Carpediol, containing 2-(4-hydroxyphenyl)ethyl-null-d-glucopyranoside or 3-null6-o-(null-1-arabinopyranosyl)-null-d-glucopyranosyl)-null-d-glucopyranosylnull-oxy-1-phenylpropene in mammals, to method of preparation and analysis of these extract, as well to safety of their usage in combination with other drugs.

    摘要翻译： 本发明涉及含有2-（4-羟苯基）乙基-β-D-吡喃葡萄糖苷或3- [6-邻 - （α-1-阿拉伯吡喃糖基） - 乙基-β-葡萄糖苷的赤藓科特殊提取物卡波西欧的抗抑郁活性， D-吡喃葡萄糖基）-β-d-吡喃葡萄糖基] - 氧基-1-苯基丙烯，以及这些提取物的制备和分析方法，以及它们与其它药物组合使用的安全性。

    Insulin secretion promoter
    63.
    发明申请
    Insulin secretion promoter 有权
    胰岛素分泌促进剂

    公开(公告)号：US20030181401A1

    公开(公告)日：2003-09-25

    申请号：US10356564

    申请日：2003-02-03

    申请人： KYOWA HAKKO KOGYO CO., LTD.

    发明人： Miho Takada ,  Toshikazu Kamiya ,  Tetsuo Endo ,  Satoshi Koizumi

    IPC分类号： A61K031/7012 ,  A61K031/715

    CPC分类号： A23K20/163 ,  A21D2/181 ,  A21D13/80 ,  A23L29/30 ,  A23L33/10 ,  A23L33/125 ,  A61K31/7012 ,  A61K31/7016 ,  A61K31/702

    摘要： Provided are a method for promoting insulin secretion, a method for suppressing the elevation of a blood glucose level, a method for ameliorating diabetes mellitus, a method for promoting growth of an animal, and a method for increasing an insulin level in breast milk. These methods comprising administering at least one member selected from the group consisting of a di- or a higher saccharide containing galactose, a derivative thereof, a saccharide containing N-acetylneuraminic acid, and a derivative thereof, to a patient in need thereof or an animal.

    摘要翻译： 提供促进胰岛素分泌的方法，抑制血糖水平升高的方法，改善糖尿病的方法，促进动物生长的方法以及增加母乳中胰岛素水平的方法。 这些方法包括向有需要的患者或动物施用至少一种选自二糖或高级糖的半乳糖，其衍生物，含有N-乙酰神经氨酸的糖及其衍生物的成员 。

    Method for normalizing insulin levels
    66.
    发明申请
    Method for normalizing insulin levels 失效
    胰岛素水平正常化的方法

    公开(公告)号：US20030092669A1

    公开(公告)日：2003-05-15

    申请号：US10280332

    申请日：2002-10-25

    申请人： Quality Vitamins, Inc.

    发明人： David I. Chapnick ,  Linda G. Chapnick

    IPC分类号： A61K031/7012 ,  A61K031/198

    CPC分类号： A61K31/7012 ,  A61K31/198 ,  A61K2300/00

    摘要： The invention is directed to a dietary supplement which contains mannoheptulose. Mannoheptulose occurs naturally in avocado fruit. The dietary supplement and its method of use can lower serum insulin levels and lower a subject's weight. The dietary supplement in its disclosed form includes a controlled release system for mannoheptulose. The dietary supplement may also include one or more amino acids.

    摘要翻译： 本发明涉及含有甘露庚酮糖的膳食补充剂。 鳄梨水果自然发生。 膳食补充剂及其使用方法可以降低血清胰岛素水平并降低受试者的体重。 其公开形式的膳食补充剂包括用于甘露庚酮酸的控释制剂。 膳食补充剂还可以包括一种或多种氨基酸。

    Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index
    67.
    发明申请
    Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index 有权
    果糖和乳糖作为低热量散装甜味剂的混合物具有降低的血糖指数

    公开(公告)号：US20030082286A1

    公开(公告)日：2003-05-01

    申请号：US10233748

    申请日：2002-09-03

    发明人： Lee R. Zehner ,  Warren L. Zehner

    IPC分类号： A23L001/236

    CPC分类号： A23G3/368 ,  A21D2/181 ,  A23G3/346 ,  A23G3/42 ,  A23G2200/04 ,  A23G2200/06 ,  A23K20/163 ,  A23K50/40 ,  A23L2/60 ,  A23L7/00 ,  A23L7/143 ,  A23L21/00 ,  A23L27/33 ,  A23L29/30 ,  A23L33/125 ,  A23L33/20 ,  A23V2002/00 ,  A61K31/7012 ,  A61K31/7016 ,  A61K45/06 ,  Y10S426/804 ,  A61K2300/00 ,  A23V2250/612 ,  A23V2250/606 ,  A23V2250/628

    摘要： Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction of their calories from nulladded sugarsnull. The fructose/lactose sweetener is included in the daily diet as a one-for-one replacement for nulladded sugarsnull in various edible formulations without sacrificing quality of taste. Sucrose can be used as a replacement for all or part of the fructose in the claimed sweetener to increase sweetness or improve certain functional properties without substantially changing caloric value. The claimed mixtures of fully-caloric sugars work synergistically to reduce available calories and blood sugar concentration. Specifically, fructose interferes strongly with normal small-intestinal absorption of lactose and interferes moderately with sucrose absorption, while lactose interferes with normal small-intestinal absorption of both sucrose and starch. Unabsorbed di- and oligosaccharides pass into the colon and cause increased growth of healthful bacteria, making the new sweetener useful as a prebiotic. No gastrointestinal symptoms of sugar intolerance were observed when the claimed sugar mixtures were ingested at normal dietary levels.

    摘要翻译： 果糖和乳糖的混合物可用于减少超重，葡萄糖损伤，糖尿病患者的热量摄入和血糖指数，或者仅仅摄取过多的热量来自“添加的糖”。 果糖/乳糖甜味剂被包括在日常饮食中，作为在各种可食用制剂中“添加糖”的一对一替代物，而不牺牲味道质量。 蔗糖可用作所要求保护的甜味剂中全部或部分果糖，以增加甜味或改善某些功能特性而不显着改变热值。 所要求的全热量糖的混合物协同地起作用以减少可用的热量和血糖浓度。 具体来说，果糖强烈地干扰了乳糖的正常小肠吸收，并与蔗糖吸收适度干扰，而乳糖干扰蔗糖和淀粉的正常小肠吸收。 未吸收的二糖和寡糖进入结肠并引起健康细菌的增长，使得新的甜味剂可用作益生元。 当所要求的糖混合物以正常饮食水平摄入时，没有观察到糖不耐症的胃肠道症状。

    Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glyemic index
    68.
    发明申请
    Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glyemic index 审中-公开
    果糖和乳糖作为低热量散装甜味剂的混合物具有降低的血糖指数

    公开(公告)号：US20030031772A1

    公开(公告)日：2003-02-13

    申请号：US09852462

    申请日：2001-05-10

    发明人： Lee R. Zehner ,  Warren L. Zehner

    IPC分类号： A23L001/236

    CPC分类号： A23G3/368 ,  A21D2/181 ,  A23G3/346 ,  A23G3/42 ,  A23G2200/04 ,  A23G2200/06 ,  A23K20/163 ,  A23K50/40 ,  A23L2/60 ,  A23L7/00 ,  A23L7/143 ,  A23L21/00 ,  A23L27/33 ,  A23L29/30 ,  A23L33/125 ,  A23L33/20 ,  A23V2002/00 ,  A61K31/7012 ,  A61K31/7016 ,  A61K45/06 ,  Y10S426/804 ,  A61K2300/00 ,  A23V2250/612 ,  A23V2250/606 ,  A23V2250/628

    摘要： Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction of their calories from nulladded sugarsnull. The fructose/lactose sweetener is included in the daily diet as a one-for-one replacement for nulladded sugarsnull in various edible formulations without sacrificing quality of taste. Sucrose can be used as a replacement for all or part of the fructose in the claimed sweetener to increase sweetness or improve certain functional properties without substantially changing caloric value. The claimed mixtures of fully-caloric sugars work synergistically to reduce available calories and blood sugar concentration. Specifically, fructose interferes strongly with normal small-intestinal absorption of lactose and interferes moderately with sucrose absorption, while lactose interferes with normal small-intestinal absorption of both sucrose and starch. Unabsorbed di- and oligosaccharides pass into the colon and cause increased growth of healthful bacteria, making the new sweetener useful as a prebiotic. No gastrointestinal symptoms of sugar intolerance were observed when the claimed sugar mixtures were ingested at normal dietary levels.

    摘要翻译： 果糖和乳糖的混合物可用于减少超重，葡萄糖损伤，糖尿病患者的热量摄入和血糖指数，或者仅仅摄取过多的热量来自“添加的糖”。 果糖/乳糖甜味剂被包括在日常饮食中，作为在各种可食用制剂中“添加糖”的一对一替代物，而不牺牲味道质量。 蔗糖可用作所要求保护的甜味剂中全部或部分果糖，以增加甜味或改善某些功能特性而不显着改变热值。 所要求的全热量糖的混合物协同地起作用以减少可用的热量和血糖浓度。 具体来说，果糖强烈地干扰了乳糖的正常小肠吸收，并与蔗糖吸收适度干扰，而乳糖干扰蔗糖和淀粉的正常小肠吸收。 未吸收的二糖和寡糖进入结肠并引起健康细菌的增长，使得新的甜味剂可用作益生元。 当所要求的糖混合物以正常饮食水平摄入时，没有观察到糖不耐症的胃肠道症状。